Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review. Issue 9 (30th September 2021)

• Record Type: Journal Article
• Authors: Mohottige, Dinushika; Manley, Harold J.; Hall, Rasheeda K.
• Is Part Of: Kidney360. Volume 2:Issue 9(2021)
• Page Start: 1510
• Page End: 1522
• Publication Date: 2021-09-30
• Subjects: geriatric and palliative nephrology -- aged -- deprescriptions -- dialysis -- kidney diseases; 616.61
• DOI: 10.34067/KID.0001942021
• Languages: English
• ISSNs: 2641-7650

Abstract

Abstract : Due to age and impaired kidney function, older adults with kidney disease are at increased risk of medication-related problems and related hospitalizations. One proa ctive approach to minimize this risk is deprescribing. Deprescribing refers to the systematic process of reducing or stopping a medication. Aside from preventing harm, deprescribing can potentially optimize patients' quality of life by aligning medications with their goals of care. For some patients, deprescribing could involve less aggressive management of their diabetes and/or hypertension. In other instances, deprescribing targets may include potentially inappropriate medications that carry greater risk of harm than benefit in older adults, medications that have questionable efficacy, including medications that have varying efficacy by degree of kidney function, and that increase medication regimen complexity. We include a guide for clinicians to utilize in deprescribing, the List, Evaluate, Shared Decision-Making, Support (LESS) framework. The LESS framework provides key considerations at each step of the deprescribing process that can be tailored for the medications and context of individu al patients. Patient characteristics or clinical events that warrant consideration of deprescribing include limited life expectancy, cognitive impairment, and health status changes, such as dialysis initiation or recent hospitalization. We acknowledge patient-, clinician-, and system-level challenges to the depre scribing process. These include patient hesitancy and challenges to discussing goals of care, clinician time constraints and a lack of evidence-based guidelines, and system-level challenges of interoperable electronic health records and limited incentives for deprescribing. However, novel evidence-based tools designed to facilitate deprescribing and future evidence on effectiveness of deprescribing could help mitigate these barriers. This review provides foundational knowledge on deprescribing as an emerging component of clinical practice and research within nephrology.